Proton pump inhibitors, fracture risk and selection bias: three studies, same database, two answers

Por de Vries, F., van Staa, T.-P., Leufkens, H. G. M.
Publicado em 2010

Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens.

Por de Vries, F P, van Der Ende, A, van Putten, J P, Dankert, J
Publicado em 1996

Use of β-Blockers and the Risk of Hip/Femur Fracture in the United Kingdom and The Netherlands

Por de Vries, F., Souverein, P. C., Cooper, C., Leufkens, H. G. M., van Staa, T. P.
Publicado em 2007

Factors Associated with Antihypertensive Medication Non-Adherence: A Cross-Sectional Study Among Lebanese Hypertensive Adults

Por Abbas H, Kurdi M, de Vries F, van Onzenoort HAW, Driessen JHM, Watfa M, Karam R
Publicado em 2020-04-01

Antipsychotic use and the risk of hip/femur fracture: a population-based case–control study

Por Pouwels, S., van Staa, T. P., Egberts, A. C. G., Leufkens, H. G. M., Cooper, C., de Vries, F.
Publicado em 2009

Complications due to bovine pericardium used to cover acrylic implants after enucleation and tubes of aqueous devices

Por De Vries, F R, Notting, I C, Marinkovic, M, Schalij-Delfos, N E, Luyten, G P M
Publicado em 2012

Potential Impact of Benzodiazepine Use on the Rate of Hip Fractures in Five Large European Countries and the United States

Por Khong, T. P., de Vries, F., Goldenberg, J. S. B., Klungel, O. H., Robinson, N. J., Ibáñez, Luisa, Petri, H.
Publicado em 2012

Fracture rate in patients with myasthenia gravis: the general practice research database

Por Pouwels, S., de Boer, A., Javaid, M. K., Hilton-Jones, D., Verschuuren, J., Cooper, C., Leufkens, H. G., de Vries, F.
Publicado em 2012

Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study

Por Pouwels, S., Lalmohamed, A., Souverein, P., Cooper, C., Veldt, B. J., Leufkens, H. G., de Boer, A., van Staa, T., de Vries, F.
Publicado em 2010

Dopaminergic drugs and the risk of hip or femur fracture: a population-based case–control study

Por Arbouw, M. E. L., Movig, K. L. L., van Staa, T. P., Egberts, A. C. G., Souverein, P. C., de Vries, F.
Publicado em 2010

Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial

Por Klop, C., de Vries, F., Vinks, T., Kooij, M. J., van Staa, T. P., Bijlsma, J. W. J., Egberts, A. C. G., Bouvy, M. L.
Publicado em 2013

Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures

Por Lalmohamed, A., Welsing, P. M. J., Lems, W. F., Jacobs, J. W. G., Kanis, J. A., Johansson, H., De Boer, A., De Vries, F.
Publicado em 2011

Risk of fractures in patients with multiple sclerosis: A population-based cohort study

Por Bazelier, M.T., van Staa, T.-P., Uitdehaag, B.M.J., Cooper, C., Leufkens, H.G.M., Vestergaard, P., Herings, R.M.C., de Vries, F.
Publicado em 2012

Heavy-Metal Concentrations in Small Mammals from a Diffusely Polluted Floodplain: Importance of Species- and Location-Specific Characteristics

Por Wijnhoven, S., Leuven, R. S. E. W., van der Velde, G., Jungheim, G., Koelemij, E. I., de Vries, F. T., Eijsackers, H. J. P., Smits, A. J. M.
Publicado em 2007

Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort

Por Bours, S., de Vries, F., van den Bergh, J. P. W., Lalmohamed, A., van Staa, T. P., Leufkens, H. G. M., Geusens, P. P. P., Drent, M., Harvey, N. C.
Publicado no Osteoporos Int (2015)

The epidemiology of fractures in Denmark in 2011

Por Driessen, J. H. M., Hansen, L., Eriksen, S. A., van Onzenoort, H. A. W., Henry, R. M. A., van den Bergh, J., Abrahamsen, B., Vestergaard, P., de Vries, F.
Publicado no Osteoporos Int (2016)

Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000–2010

Por Klop, C., Gibson-Smith, D., Elders, P. J. M., Welsing, P. M. J., Leufkens, H. G. M., Harvey, N. C., Bijlsma, J. W. J., van Staa, T.-P., de Vries, F.
Publicado no Osteoporos Int (2015)

Use of anti-depressants and the risk of fracture of the hip or femur

Por van den Brand, M. W. M., Samson, M. M., Pouwels, S., van Staa, T. P., Thio, B., Cooper, C., Leufkens, H. G. M., Egberts, A. C. G., Verhaar, H. J. J., de Vries, F.
Publicado em 2009

Use of anti-depressants and the risk of fracture of the hip or femur

Por van den Brand, M. W. M., Pouwels, S., Samson, M. M., van Staa, T. P., Thio, B., Cooper, C., Leufkens, H. G. M., Egberts, A. C. G., Verhaar, H. J. J., de Vries, F.
Publicado no Osteoporos Int (2009)

Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: variation by age, sex, geographic location and ethnicity

Por van der Velde, R.Y., Wyers, C. E., Teesselink, E., Geusens, P. P. M. M., van den Bergh, J. P. W, de Vries, F., Cooper, C., Harvey, N. C., van Staa, T. P.
Publicado no Bone (2016)